Tang receives funding for movement disorder research

Weiping Tang, assistant professor in the Pharmaceutical Sciences Division, was awarded NIH R21 funding for his proposal “Identifying novel therapeutic compounds for early onset dystonia.” Early onset torsion dystonia (EOTD) is a movement disorder characterized …

Johnson featured speaker at Academy Evening

Jeff Johnson, professor in the Pharmaceutical Sciences Division, spoke on the topic “Alzheimer’s and More: Halting the Progression of Neurological Diseases” at the Wisconsin Academy of Sciences Arts and Letters Academy Evening on Tuesday, October …

Research makes strides in pain relief for pets

Initial studies are promising for injectable liposome-encapsulated opioids developed by Tim Heath, associate professor emeritus in the Pharmaceutical Sciences Division, and Lisa Krugner-Higby, clinical instructor, UW Research Animal Resources Center. The drug formulation is the …

Zografi to speak in China

George Zografi, dean and professor emeritus, has been invited to speak at the 1st Asian Arden Conference in Beijing, China in October 2008. The conference is co-sponsored by the American Association of Pharmaceutical Scientists and …

Hak Auth accepts naval position

Hak Auth, PhD ’08, has accepted a position as a scientist-officer in the U.S. Navy Medical Services Corps. Auth will be reporting to Jacksonville, Florida later this month to begin his naval career. During his …

FDA explores oversight of nanotechnology

The nanotechnology research of Darin Furgeson, assistant professor in the Pharmaceutical Sciences Division, is referenced in the July 25 edition of Science Progress. The Food and Drug Administration’s Nanotechnology Task Force has been created to …

Start-up company begins testing Alzheimer’s drug

Mithridion, a drug development company, co-founded by Jeff Johnson, professor in the Pharmaceutical Sciences Division, began a Phase 1 clinical trial of MCD-386, a small-molecule compound designed to treat Alzheimer’s patients. As highlighted in the …